These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3332146)

  • 1. Modification of the sponge allograft model to study the immune response to bone marrow cells.
    Moen RC; Schears GJ; Hong R
    Bone Marrow Transplant; 1987 Apr; 1(4):389-96. PubMed ID: 3332146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of natural killer activity in sponge matrix allografts.
    Hoffman RA; Ascher NL; Jordan ML; Migliori RJ; Simmons RL
    J Immunol; 1988 Mar; 140(5):1702-10. PubMed ID: 3257981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo mechanisms of alloreactivity. III. Development of donor-specific antibody in sponge matrix allografts.
    Sirinek LP; Zinn NE; Ferguson RM; Orosz CG
    Transplantation; 1986 Mar; 41(3):349-56. PubMed ID: 3952801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
    Dennert G; Anderson CG; Warner J
    J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of natural killer cells in the allograft response.
    Hoffman RA; Jordan ML; Ascher NL; Simmons RL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):342-4. PubMed ID: 3274782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigens on mouse natural killer cells: use of monoclonal antibodies to inhibit or to enrich cytotoxic activity.
    Seaman WE; Talal N; Herzenberg LA; Herzenberg LA; Ledbetter JA
    J Immunol; 1981 Sep; 127(3):982-6. PubMed ID: 6790624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation of cytotoxic T cells within sponge matrix allografts.
    Ascher NL; Chen S; Hoffman RA; Simmons RL
    J Immunol; 1983 Aug; 131(2):617-21. PubMed ID: 6345671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1.
    Hogarth PM; Potter TA; Cornell FN; McLachlan R; McKenzie IF
    J Immunol; 1980 Oct; 125(4):1618-24. PubMed ID: 6997382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.
    Merluzzi VJ; Savage DM; Smith MD; Last-Barney K; Mertelsmann R; Moore MA; Welte K
    J Immunol; 1985 Sep; 135(3):1702-6. PubMed ID: 3894518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M; Hurme M
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E; Savary CA; Stringfellow DA
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.